Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 37 Nausea 25 Neoplasms 12 Breast Neoplasms 6 Lymphoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Leukemia 2 Hematologic Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Weight Loss 1 Solid Tumors 1 Sarcoma 1 Radiation Injuries 1 Pancreatic Neoplasms 1 Pain 1 Neoplasms, Germ Cell and Embryonal 1 Nausea With Vomiting Chemotherapy-Induced 1 Melanoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Inflammatory Breast Neoplasms 1 Hematologic Diseases 1 Glioma 1

Interventions

Fentanyl 23 Analgesia 22 Morphine 19 Acupuncture Therapy 18 Zoledronic Acid 15 Oxycodone 14 Acetaminophen 14 Ketamine 13 Radiotherapy 12 Therapeutics 11 Methadone 11 Lidocaine 11 nabiximols 10 Ibandronic Acid 10 Hydromorphone 10 Bupivacaine 10 Surveys and Questionnaires 8 Ropivacaine 8 Psychiatric Rehabilitation 7 Early Intervention, Educational 7 Saline Solution 6 Music Therapy 6 Cryotherapy 6 Cryosurgery 6 Yoga 5 Water 5 Tapentadol 5 Pregabalin 5 Methods 5 Massage 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain × Palonosetron × Clear all

NCT05315999 2025-03-19

ProTreat

University Hospital Freiburg

Phase 2 Completed

Nausea, Pain, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡